Literature DB >> 26580889

Treatment of Periorbital Veins With Long-Pulse Nd:YAG Laser.

David L Chen, Joel L Cohen.   

Abstract

Periorbital veins (POVs) are a common cosmetic concern. Anatomically, POVs are formed by superficial facial veins that start from the bridge of the nose, travel as supraorbital and infraorbital veins, and join venous branches from the lateral forehead and scalp. In patients with fair skin, or in patients whose facial skin is atrophied, POVs can become prominent. This can lead to a fatigued appearance, with perceived "dark circles" around the patients' eyes. Previously described surgical therapies for prominent POVs are invasive and can leave unsightly scars, and sclerotherapy has been reported to lead to embolization that could lead to blindness. Here, we give examples of the use of 1,064 nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser to non-invasively treat or at least minimize prominent POVs. We discuss various techniques, and review treatment schedules to achieve the optimal cosmetic outcome. Furthermore, potential pitfalls, such as local site reaction and laser-specific tissue damage, are explored. Overall, Nd:YAG laser does appear to be a safe and effective treatment for POVs that requires minimal post-treatment care.

Entities:  

Mesh:

Year:  2015        PMID: 26580889

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

1.  Commentary on: Infraorbital Hyaluronic Acid Filler: Common Aesthetic Side Effects With Treatment and Prevention Options.

Authors:  Mark G Albert
Journal:  Aesthet Surg J Open Forum       Date:  2022-02-01

Review 2.  Treatments of Infra-Orbital Dark Circles by Various Etiologies.

Authors:  Kui Young Park; Hyun Jung Kwon; Choon Shik Youn; Seong Jun Seo; Myeong Nam Kim
Journal:  Ann Dermatol       Date:  2018-08-28       Impact factor: 1.444

3.  Successful Treatment of Reticular Blue Veins of the Lower Eyelid by Long-Pulse Nd: YAG - Case Report with 8-Year Follow-Up.

Authors:  Alberto Goldman; Torello Lotti; Georgi Tchernev; Uwe Wollina
Journal:  Open Access Maced J Med Sci       Date:  2017-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.